Jˇhannes Reynisson
Jˇhannes Reynisson
School of Pharmacy, Keele University, United Kingdom
Verified email at - Homepage
Cited by
Cited by
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
L Ioakimidis, L Thoukydidis, A Mirza, S Naeem, J Reynisson
QSAR & Combinatorial Science 27 (4), 445-456, 2008
Sorption and biodegradation of organic micropollutants during river bank filtration: A laboratory column study
C Bertelkamp, J Reungoat, ER Cornelissen, N Singhal, J Reynisson, ...
Water research 52, 231-241, 2014
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
MV Babak, SM Meier, KVM Huber, J Reynisson, AA Legin, MA Jakupec, ...
Chemical Science 6 (4), 2449-2456, 2015
Characteristics of known drug space. Natural products, their derivatives and synthetic drugs
R Bade, HF Chan, J Reynisson
European journal of medicinal chemistry 45 (12), 5646-5652, 2010
Hit generation and exploration: imidazo [4, 5-b] pyridine derivatives as inhibitors of Aurora kinases
V Bavetsias, C Sun, N Bouloc, J█ Reynisson, P Workman, ...
Bioorganic & medicinal chemistry letters 17 (23), 6567-6571, 2007
Intercalation of trioxatriangulenium ion in DNA: binding, electron transfer, X-ray crystallography, and electronic structure
J Reynisson, GB Schuster, SB Howerton, LD Williams, RN Barnett, ...
Journal of the American Chemical Society 125 (8), 2072-2083, 2003
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety
A Zakharenko, T Khomenko, S Zhukova, O Koval, O Zakharova, ...
Bioorganic & Medicinal Chemistry 23 (9), 2044-2052, 2015
Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinicalá…
V Bavetsias, JM Large, C Sun, N Bouloc, M Kosmopoulou, M Matteucci, ...
Journal of medicinal chemistry 53 (14), 5213-5228, 2010
Anticancer Ruthenium(η6-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives
F Aman, M Hanif, WA Siddiqui, A Ashraf, LK Filak, J Reynisson, ...
Organometallics 33 (19), 5546-5553, 2014
DFT calculations on the electrophilic reaction with water of the guanine and adenine radical cations. A model for the situation in DNA
J Reynisson, S Steenken
Physical Chemistry Chemical Physics 4 (3), 527-532, 2002
New water-soluble copper (II) complexes with morpholine–thiosemicarbazone hybrids: Insights into the anticancer and antibacterial mode of action
K Ohui, E Afanasenko, F Bacher, RLX Ting, A Zafar, N Blanco-Cabra, ...
Journal of medicinal chemistry 62 (2), 512-530, 2018
Synthesis and cytotoxicity of thieno [2, 3-b] pyridine and furo [2, 3-b] pyridine derivatives
JM Hung, HJ Arabshahi, E Leung, J Reynisson, D Barker
European journal of medicinal chemistry 86, 420-437, 2014
Half‐Sandwich Ruthenium (II) Biotin Conjugates as Biological Vectors to Cancer Cells
MV Babak, D Plażuk, SM Meier, HJ Arabshahi, J Reynisson, B Rychlik, ...
Chemistry–A European Journal 21 (13), 5110-5117, 2015
The effect of PLC-γ2 inhibitors on the growth of human tumour cells
L Feng, I Reynisdˇttir, J Reynisson
European journal of medicinal chemistry 54, 463-469, 2012
Investigation of the incidence of “undesirable” molecular moieties for high-throughput screening compound libraries in marketed drug compounds
P Axerio-Cilies, IP Casta˝eda, A Mirza, J Reynisson
European journal of medicinal chemistry 44 (3), 1128-1134, 2009
New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties
T Khomenko, A Zakharenko, T Odarchenko, HJ Arabshahi, V Sannikova, ...
Bioorganic & Medicinal Chemistry 24 (21), 5573-5581, 2016
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models
AL Zakharenko, OA Luzina, DN Sokolov, VI Kaledin, VP Nikolin, ...
European Journal of Medicinal Chemistry 161, 581-593, 2019
The identification of novel PLC-[gamma] inhibitors using virtual high throughput screening
J█ Reynisson, C O'Neill, J Day, L Patterson, E McDonald, P Workman, ...
Bioorganic & medicinal chemistry 17 (8), 3169-3176, 2009
Mutagenicity and DNA adduct formation by the urban air pollutant 2-nitrobenzanthrone
VM Arlt, H Glatt, G Gamboa da Costa, J Reynisson, T Takamura-Enya, ...
Toxicological sciences 98 (2), 445-457, 2007
Size estimation of chemical space: how big is it?
KLM Drew, H Baiman, P Khwaounjoo, B Yu, J Reynisson
Journal of Pharmacy and Pharmacology 64 (4), 490-495, 2012
The system can't perform the operation now. Try again later.
Articles 1–20